STERNE, KESSLER, GOLDSTEIN & FOX


Associated tags: Invention, Engineering, Sterne, Environment, Science, Student, IP, University, Patent, Pharmaceutical industry, PTAB, Lawyer

Locations: DISTRICT OF COLUMBIA, GOLDSTEIN, WASHINGTON

Sterne Kessler Garners "Best New Office Space" at Washington Business Journal's 2024 Best Real Estate Deals Awards

Retrieved on: 
Tuesday, April 30, 2024

WASHINGTON, April 30, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox accepted the "Best New Office Space" award at the recently held 2024 Washington Business Journal's Best Real Estate Deals Awards.

Key Points: 
  • WASHINGTON, April 30, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox accepted the "Best New Office Space" award at the recently held 2024 Washington Business Journal's Best Real Estate Deals Awards.
  • In its 27th year, the annual program recognizes the Washington area's most pronounced real estate deals closed in the prior year.
  • Sterne Kessler's new 76,000 square-foot space occupies the top four floors of 1101 K Street NW, including the eleventh floor penthouse.
  • Visitors are welcomed by stunning views of the city, abundant natural light, a plethora of plants, and design materials with exquisite textures and color.

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Retrieved on: 
Friday, January 5, 2024

WASHINGTON, Jan. 5, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox secured a victory on behalf of Teva Pharmaceuticals in the U.S. Court District Court for the District of New Jersey in a case involving a patent-infringement suit filed by Corcept Therapeutics.

Key Points: 
  • WASHINGTON, Jan. 5, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox secured a victory on behalf of Teva Pharmaceuticals in the U.S. Court District Court for the District of New Jersey in a case involving a patent-infringement suit filed by Corcept Therapeutics.
  • On December 29, 2023, the district court held that Teva does not infringe the two patents asserted at trial, finding that Corcept had failed to show that direct infringement is likely or that Teva's label would induce infringement.
  • Teva Pharmaceuticals USA, Inc. is a leading manufacturer of generic and proprietary drug products.
  • Corcept Therapeutics, Inc., the holder of the Korlym NDA, filed a Hatch-Waxman lawsuit against Teva alleging infringement of two patents listed in the Orange Book for Korlym.

Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle

Retrieved on: 
Friday, January 5, 2024

WASHINGTON, Jan. 5, 2024 /PRNewswire/ -- On January 2, 2024, Sterne, Kessler, Goldstein & Fox earned a patent infringement victory at the U.S. Court of Appeals for the Federal Circuit for client SweeGen Inc. regarding a natural non-caloric sweetener used in food and drinks.

Key Points: 
  • WASHINGTON, Jan. 5, 2024 /PRNewswire/ -- On January 2, 2024, Sterne, Kessler, Goldstein & Fox earned a patent infringement victory at the U.S. Court of Appeals for the Federal Circuit for client SweeGen Inc. regarding a natural non-caloric sweetener used in food and drinks.
  • The Federal Circuit affirmed a district court decision granting defendant-appellee SweeGen's motion for Summary Judgment of patent invalidity, holding all claims of the asserted patents invalid for inadequate written description under 35 U.S.C.
  • § 112, and further holding certain claims invalid for claiming ineligible subject matter under 35 U.S.C.
  • v. Sweegen, Inc., et al.

Sterne Kessler Elects Six New Directors in 2024

Retrieved on: 
Thursday, January 4, 2024

WASHINGTON, Jan. 4, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox is proud to announce that six attorneys have been elected to the directorship effective January 1, 2024.

Key Points: 
  • WASHINGTON, Jan. 4, 2024 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox is proud to announce that six attorneys have been elected to the directorship effective January 1, 2024.
  • "It is an honor to congratulate our six new directors on this well-deserved milestone.
  • Read more about Sterne Kessler's new directors:
    David W. Haars , is a member of Sterne Kessler's Electronics Practice Group.
  • He regularly represents both complainants and respondents across a wide range of technologies in Section 337 investigations before the ITC.

Sterne Kessler Honored as US Post-Grant Firm of the Year at Global IP Awards

Retrieved on: 
Friday, October 20, 2023

The Global IP Awards, organized by leading intellectual property publications Intellectual Asset Management (IAM) and World Trademark Review (WTR), recognize the outstanding achievements of law firms and their lawyers in litigation, prosecution, and transactional work.

Key Points: 
  • The Global IP Awards, organized by leading intellectual property publications Intellectual Asset Management (IAM) and World Trademark Review (WTR), recognize the outstanding achievements of law firms and their lawyers in litigation, prosecution, and transactional work.
  • The firm also earned top tier recognition in Managing IP 2023 "IP Stars" guide , which ranked the firm in "Tier 1" for PTAB litigation.
  • I am extremely proud of our PTAB trials team for their accomplishments and for winning this and other recent awards.
  • We have a deep bench of talent poised for ongoing success in the years ahead," added Sterne Kessler Managing Director Michael B. Ray .

Sterne Kessler Publishes "2021 PTAB Year in Review: Analysis & Trends" Report

Retrieved on: 
Monday, March 7, 2022

WASHINGTON, March 7, 2022 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox is proud to announce the publication of the 2021 PTAB Year in Review: Analysis & Trends.

Key Points: 
  • WASHINGTON, March 7, 2022 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox is proud to announce the publication of the 2021 PTAB Year in Review: Analysis & Trends.
  • The introduction of the PTAB as part of the America Invents Act over a decade ago has forever changed patent litigation.
  • The report concludes with examining ex parte reexaminations, which have recently moved back to center stage.
  • The publication, 2021 PTAB Year in Review: Analysis & Trends, is available for viewing in its entirety and as individual articles on the firm's website here in both HTML and PDF formats.

Sterne Kessler Releases "2021 Design Patents Year in Review: Analysis and Trends" Report

Retrieved on: 
Wednesday, March 2, 2022

WASHINGTON, March 2, 2022 /PRNewswire/ --Sterne, Kessler, Goldstein & Fox has released a new publication, 2021 Design Patents Year in Review: Analysis and Trends.

Key Points: 
  • WASHINGTON, March 2, 2022 /PRNewswire/ --Sterne, Kessler, Goldstein & Fox has released a new publication, 2021 Design Patents Year in Review: Analysis and Trends.
  • The report was edited by Director Tracy-Gene G. Durkin and authored by Directors Daniel A. Gajewski , Deirdre M. Wells , and Ivy Clarice Estoesta .
  • The report also provides an update on recent regulatory changes taking place globally with respect to design protection and enforcement.
  • The full 2021 Design Patents Year in Review: Analysis and Trends report and individual articles are available on Sterne Kessler's website in HTML and PDF formats here .

Sterne Kessler Releases Report "Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions"

Retrieved on: 
Wednesday, February 9, 2022

WASHINGTON, Feb. 9, 2022 /PRNewswire/ --Sterne, Kessler, Goldstein & Fox is pleased to announce the publication of Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions.

Key Points: 
  • WASHINGTON, Feb. 9, 2022 /PRNewswire/ --Sterne, Kessler, Goldstein & Fox is pleased to announce the publication of Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions.
  • Furthermore, the publication presents Federal Circuit data and trends for major origins of appeals, average appeal pendency, appeal disposition types, and appeal outcomes.
  • The full Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions report and individual articles are available on Sterne Kessler's website in HTML and PDF formats here .
  • In the coming months, the firm will publish a companion report concerning notable 2021 PTAB decisions.

Sterne Kessler Elects Four New Directors and Promotes Four Associates to Counsel

Retrieved on: 
Wednesday, January 12, 2022

Additionally, the firm congratulates four associates on their promotion to counsel: Joshua G. McCoy*, Stephen A. Merrill, Harish Ruchandani, and Tyler Tassone.

Key Points: 
  • Additionally, the firm congratulates four associates on their promotion to counsel: Joshua G. McCoy*, Stephen A. Merrill, Harish Ruchandani, and Tyler Tassone.
  • "On behalf of Sterne Kessler, I am excited to congratulate our newest directors and counsels.
  • The firm's new directors are:
    Tyler J. Dutton is a director in Sterne Kessler's Electronics Practice Group.
  • The firm's new counsel are:
    Joshua G. McCoy is counsel in Sterne Kessler's Biotechnology & Chemical Practice Group.

Sterne Kessler's IP Hot Topics Podcast Wraps First Quarter Episodes with Howard University President

Retrieved on: 
Wednesday, April 21, 2021

b'WASHINGTON, April 20, 2021 /PRNewswire/ --The podcast IP Hot Topics , presented by Sterne, Kessler, Goldstein & Fox , closed out the first quarter of the year by hosting the President of Howard University, Dr. Wayne A.I.

Key Points: 
  • b'WASHINGTON, April 20, 2021 /PRNewswire/ --The podcast IP Hot Topics , presented by Sterne, Kessler, Goldstein & Fox , closed out the first quarter of the year by hosting the President of Howard University, Dr. Wayne A.I.
  • The IP Hot Topics podcast is available on Apple Podcasts, Spotify, and SoundCloud, as well as the "Multimedia" section of the firm\'s website www.sternekessler.com .\nFull topics and episodes are available below:\nInnovation Conversations: Dr. Wayne A.I.
  • Frederick : Sterne Kessler Director R. Wilson "Trey" Powers III, Ph.D. and Director of Marketing & Communications Kathryn Holmes Johnson spoke with Dr. Wayne A.I.
  • Highly experienced attorneys from Sterne Kessler, a top-tier IP specialty firm based in Washington, DC, discuss what is happening, why it is happening and what action steps IP stakeholders may want to take as a result.